Baylor College of Medicine

ENX-102 for the Treatment of Generalized Anxiety Disorder (H-53469)

Description

Content

The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD).

If eligible, participants will receive the study treatments and all study-related care at no cost. Compensation of up to $1,072 provided for time and travel.

IRB: H-53469

Status:

Active

Created:

Back to topback-to-top